How to Buy Cipla Ltd Shares?
You can easily buy the stocks/shares of Cipla Ltd (CIPLA) on Tickertape or through broker platform by opening a Demat & Trading account onlineWhat is the Share Price of Cipla Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of CIPLA as on 15th May 2025 is ₹1493.98What is the return on Cipla Ltd share?
The past returns of Cipla Ltd (CIPLA) share are- Past 1 week: N/A
- Past 1 month: -66.76
- Past 3 months: 2.96
- Past 6 months: 4.00
- Past 1 year: -2.55
- Past 3 years: 57.65
- Past 5 years: 133.85
What is the Dividend yield % on Cipla Ltd share?
The current dividend yield of Cipla Ltd (CIPLA) is 1.06What is the Market Cap of Cipla Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Cipla Ltd (CIPLA) is ₹121415.60Cr as of 15th May 2025What is the 52 Week High and Low of Cipla Ltd?
The 52-week high and low of Cipla Ltd (CIPLA) is ₹1702.05 and ₹1335.What is the PE and PB ratio of Cipla Ltd?
The P/E (price-to-earnings) and P/B (price-to-book) ratios of Cipla Ltd are 23.03 and 4.53 respectively.Which sector does Cipla Ltd belong to?
Cipla Ltd (CIPLA) belongs to the Health Care sector & Pharmaceuticals sub-sector.What are the peers or stocks similar to Cipla Ltd?
The peers or stocks similar to Cipla Ltd are: and many others.Can't decide whether or not to buy Cipla Ltd?
Worry no more! Login to Tickertape and check out Cipla Ltd (CIPLA) scorecard & all the relevant insights today5. Test Stocks FAQ What is the 52 Week High and Low of Cipla Ltd?
The 52-week high and low of Cipla Ltd (CIPLA) is ₹1702.05 and ₹1335.1. Test Stocks FAQ for Cipla Ltd Shares?
You can easily buy the stocks/shares of Cipla Ltd (CIPLA) on Tickertape or through broker platform by opening a Google & Trading account online3. Test Stocks FAQ What is the Share Price of Cipla Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of CIPLA as on 15th May 2025 is ₹1493.98
Cipla Ltd
CIPLA Share Price
1,493.980.05% (-0.82)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
CIPLA Performance & Key Metrics
CIPLA Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 23.03 | 4.53 | 1.06% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.21 | 6.66 | 0.83% |
CIPLA Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
CIPLA Company Profile
Cipla Limited is a pharmaceutical company. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology & cosmetology, diabetes, HIV/AIDS, infectious diseases & critical care, malaria etc.
SUNPHARMA
PE Ratio
37.00
37.00
1Y Return
11.72%
11.72%
Buy Reco %
89.19
89.19
DRREDDY
PE Ratio
20.02
20.02
1Y Return
11.76%
11.76%
Buy Reco %
82.05
82.05
TORNTPHARM
PE Ratio
57.53
57.53
1Y Return
13.13%
13.13%
Buy Reco %
67.74
67.74
MANKIND
PE Ratio
49.29
49.29
1Y Return
6.30%
6.30%
Buy Reco %
—
—
ZYDUSLIFE
PE Ratio
21.65
21.65
1Y Return
10.60%
10.60%
Buy Reco %
46.67
46.67
CIPLA Sentiment Analysis
CIPLA Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
CIPLA Stock Summary · January 2025
Company is navigating a complex landscape characterized by declining market share in deposits, challenges in meeting Priority Sector Lending (PSL) obligations, and fluctuations in current account flows. Despite these hurdles, the bank is focusing on enhancing customer engagement and service delivery to drive deposit growth, with recent monthly inflows showing a positive trend. The management emphasizes a strategic approach to maintaining profitability over aggressive expansion, particularly in light of competitive pressures and a tight liquidity environment. Efforts to improve operational efficiencies through digitization and a commitment to stable cost management are underway, alongside a proactive strategy to reduce borrowings and strengthen the balance sheet. Overall, while facing short-term challenges, the bank remains optimistic about future performance and is committed to achieving sustainable growth through strategic investments and improved customer outreach.
CIPLA Stock Growth Drivers
CIPLA Stock Growth Drivers
2Focus on Sustainable Growth
Company is prioritizing profitable growth over mere expansion, emphasizing a strategy that encourages ground-level teams
Stable Financial Metrics
The company has maintained a return on assets (ROA) of 1.9% post-merger, showcasing stability in
CIPLA Stock Challenges
CIPLA Stock Challenges
4Deposit Growth Shortfalls
The company has experienced deposit growth that has not met expectations, attributed to seasonal trends
Loan Growth Concerns
There is uncertainty regarding the company's loan deposit ratio (LDR) and its implications for loan
CIPLA Forecast
What are forecasts?
What are forecasts?
Forecasting uses historical data as inputs to make informed predictive estimates determining the direction of future trends. Price, revenue & earnings forecasts represent where the stock level, business prospects and profits are potentially expected to be at the end of the forecast period
CIPLA Forecasts
Price
Revenue
Earnings
CIPLA Share Price Forecast
CIPLA Share Price Forecast
2025
Current
₹1,505.20
Baseline
Forecast for Jun 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹1,505.20
Baseline
Forecast for Jun 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
CIPLA Company Revenue Forecast
CIPLA Company Revenue Forecast
2025
Current
₹28.41
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2025
Current
₹28.41
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
CIPLA Stock EPS (Earnings Per Share) Forecast
CIPLA Stock EPS (Earnings Per Share) Forecast
2025
Current
₹65.29
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹65.29
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
CIPLA
CIPLA
Income
Balance Sheet
Cash Flow
Annual Normal View
CIPLA Income Statement
CIPLA Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 14,622.98 | 15,513.36 | 16,838.98 | 17,476.19 | 19,425.58 | 22,044.25 | 23,228.57 | 26,520.66 | 28,409.49 | 28,409.49 | ||||||||||
Raw Materials | 5,206.16 | 5,671.36 | 5,737.45 | 6,236.18 | 7,544.60 | 9,220.29 | 8,348.28 | 8,756.54 | 20,419.72 | 20,419.72 | ||||||||||
| Power & Fuel Cost | 251.73 | 298.82 | 335.11 | 327.43 | 308.26 | 331.03 | 353.61 | 364.84 | ||||||||||||
| Employee Cost | 2,633.82 | 2,690.10 | 2,856.53 | 3,027.01 | 3,251.83 | 3,529.91 | 3,830.08 | 4,310.04 | ||||||||||||
| Selling & Administrative Expenses | 2,157.79 | 2,353.98 | 2,734.65 | 2,895.69 | 2,417.36 | 3,141.75 | 3,502.92 | 3,829.37 | ||||||||||||
| Operating & Other expenses | 1,669.00 | 1,392.59 | 1,601.36 | 1,439.69 | 1,385.11 | 1,169.70 | 1,873.68 | 2,417.07 | ||||||||||||
EBITDA | 2,704.48 | 3,106.51 | 3,573.88 | 3,550.19 | 4,518.42 | 4,651.57 | 5,320.00 | 6,842.80 | 7,989.77 | 7,989.77 | ||||||||||
| Depreciation/Amortization | 1,322.93 | 1,322.82 | 1,326.31 | 1,174.65 | 1,067.66 | 1,051.95 | 1,172.11 | 1,051.02 | 1,106.95 | 1,106.95 | ||||||||||
| PBIT | 1,381.55 | 1,783.69 | 2,247.57 | 2,375.54 | 3,450.76 | 3,599.62 | 4,147.89 | 5,791.78 | 6,882.82 | 6,882.82 | ||||||||||
| Interest & Other Items | 159.38 | 114.23 | 168.43 | 197.36 | 160.70 | 106.35 | 109.54 | 89.88 | 62.01 | 62.01 | ||||||||||
| PBT | 1,222.17 | 1,669.46 | 2,079.14 | 2,178.18 | 3,290.06 | 3,493.27 | 4,038.35 | 5,701.90 | 6,820.81 | 6,820.81 | ||||||||||
| Taxes & Other Items | 215.78 | 258.93 | 551.44 | 631.66 | 885.19 | 976.52 | 1,236.44 | 1,580.35 | 1,548.29 | 1,548.29 | ||||||||||
| Net Income | 1,006.39 | 1,410.53 | 1,527.70 | 1,546.52 | 2,404.87 | 2,516.75 | 2,801.91 | 4,121.55 | 5,272.52 | 5,272.52 | ||||||||||
| EPS | 12.52 | 17.53 | 18.97 | 19.19 | 29.82 | 31.20 | 34.72 | 51.06 | 65.29 | 65.31 | ||||||||||
| DPS | 2.00 | 3.00 | 3.00 | 4.00 | 5.00 | 5.00 | 8.50 | 13.00 | 16.00 | 26.00 | ||||||||||
| Payout ratio | 0.16 | 0.17 | 0.16 | 0.21 | 0.17 | 0.16 | 0.24 | 0.25 | 0.25 | 0.40 |
CIPLA Company Updates
FY 2025FY 2025
Investor Presentation
Jan 28PDF
CIPLA Stock Peers
What are peers and why compare against them?
What are peers and why compare against them?
A stock's peers are companies which have similar business interests, operations and belong to the same industry sector. Comparing various metrics against peers can give valuable insights on whether the company's stock is over/under-valued and the company's growth outlook vs the industry as a whole
CIPLA Past Performance & Peer Comparison
CIPLA Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation-basic on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Cipla Ltd | 23.03 | 4.53 | 1.06% |
| Sun Pharmaceutical Industries Ltd | 37.00 | 6.03 | 0.95% |
| Dr Reddy's Laboratories Ltd | 20.02 | 4.01 | 0.59% |
| Torrent Pharmaceuticals Ltd | 57.53 | 16.03 | 0.99% |
CIPLA Stock Price Comparison
Compare CIPLA with any stock or ETFCompare CIPLA with any stock or ETF
CIPLA
CIPLA Holdings
CIPLA Shareholdings
What are shareholdings?
What are shareholdings?
Apart from retail investors, a company’s shares are held by promoters, foreign & domestic institutions (large investors) and mutual funds. Promoters are the ship captains and control the company’s direction. Along with institutional and mutual fund holdings, a change in their holdings can indicate performance outlook for the stock
CIPLA Promoter Holdings Trend
CIPLA Promoter Holdings Trend
Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has decreased by 1.73%
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
CIPLA Institutional Holdings Trend
CIPLA Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
CIPLA Shareholding Pattern
CIPLA Shareholding Pattern
CIPLA Shareholding History
CIPLA Shareholding History
Foreign Institutions
Mutual Funds Invested in CIPLA
Mutual Funds Invested in CIPLA
No mutual funds holding trends are available
Top 5 Mutual Funds holding Cipla Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 2.4819% | Percentage of the fund’s portfolio invested in the stock 3.98% | Change in the portfolio weight of the stock over the last 3 months 3.98% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 8/65 (+5) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.6784% | Percentage of the fund’s portfolio invested in the stock 5.01% | Change in the portfolio weight of the stock over the last 3 months 5.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 5/59 (+8) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.6139% | Percentage of the fund’s portfolio invested in the stock 0.76% | Change in the portfolio weight of the stock over the last 3 months 0.76% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 24/96 (-5) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing CIPLA stock
smallcases containing CIPLA stock
A smallcase is a basket of stocks/ETFs that represents an idea or theme.Diversify your risk and buy smallcases that have Cipla Ltd
CIPLA Events
CIPLA Events
CIPLA Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
CIPLA has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 1.06%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹10.64 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
What are dividends?
What are dividends?
Dividends are a portion of earnings that a company distributes to all its shareholders every year. Dividend return is one of the most important things to be considered while investing for long term. It’s the additional return on top of what investors earn through price appreciation
CIPLA Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
CIPLA has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 1.06%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹10.64 every year
CIPLA Upcoming Dividends
CIPLA Upcoming Dividends
Cash Dividend
Ex DateEx DateJun 27, 2025
Special
Special | Div/Share: ₹3.00
Dividend/Share
₹3.00
Ex DateEx Date
Jun 27, 2025
Cash Dividend
Ex DateEx DateJun 27, 2025
Final
Final | Div/Share: ₹13.00
Dividend/Share
₹13.00
Ex DateEx Date
Jun 27, 2025
CIPLA Past Dividends
CIPLA Past Dividends
Cash Dividend
Ex DateEx DateAug 2, 2024
Final
Final | Div/Share: ₹13.00
Dividend/Share
₹13.00
Ex DateEx Date
Aug 2, 2024
Cash Dividend
Ex DateEx DateAug 1, 2024
Final
Final | Div/Share: ₹13.00
Dividend/Share
₹13.00
Ex DateEx Date
Aug 1, 2024
Cash Dividend
Ex DateEx DateAug 8, 2022
Final
Final | Div/Share: ₹5.00
Dividend/Share
₹5.00
Ex DateEx Date
Aug 8, 2022
Cash Dividend
Ex DateEx DateAug 9, 2021
Final
Final | Div/Share: ₹5.00
Dividend/Share
₹5.00
Ex DateEx Date
Aug 9, 2021
Cash Dividend
Ex DateEx DateMar 19, 2020
Special
Special | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Mar 19, 2020
CIPLA Stock News & Opinions
CIPLA Stock News & Opinions
Articles & Videos
Spotlight
Cipla Ltd spurts 0.42%, up for fifth straight session
Cipla Ltd is up for a fifth straight session today. The stock is quoting at Rs 1517.2, up 0.42% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.38% on the day, quoting at 25199.55. The Sensex is at 82711.36, up 0.39%. Cipla Ltd has gained around 0.37% in last one month. Meanwhile, Nifty Pharma index of which Cipla Ltd is a constituent, has gained around 4.47% in last one month and is currently quoting at 21948, up 0.45% on the day. The volume in the stock stood at 6.69 lakh shares today, compared to the daily average of 19.71 lakh shares in last one month. The benchmark June futures contract for the stock is quoting at Rs 1524.2, up 0.71% on the day. Cipla Ltd is down 1.54% in last one year as compared to a 8.05% jump in NIFTY and a 11.69% jump in the Nifty Pharma index.The PE of the stock is 24.77 based on TTM earnings ending March 25.Powered by Capital Market - Live
4 days agoCapital Market - Live
Corporate
Cipla announced incorporation of subsidiary - CiplaRna GmbH' in Germany
Cipla announced that Cipla (EU), UK, a wholly owned subsidiary of the Company, has incorporated a new wholly owned subsidiary named 'CiplaRna GmbH' in Germany, effective 28 May 2025. CiplaRna has been incorporated with the objective of establishing a laboratory for mRNA-based formulation and drug development support.Powered by Capital Market - Live
2 weeks agoCapital Market - Live
Corporate
Jay Precision Pharmaceuticals acquires 26% stake in AMPIN Energy C&I Eighteen
Jay Precision Pharmaceuticals, subsidiary of Cipla, has completed acquisition of 26% stake in AMPIN Energy C&I Eighteen on 28 May 2025. Powered by Capital Market - Live
2 weeks agoCapital Market - Live
Corporate
Cipla to convene AGM
Cipla announced that the 89th Annual General Meeting(AGM) of the company will be held on 16 July 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Spotlight
Cipla's Goa API facility receives VAI status from USFDA
According to an exchange filing dated 20 January 2025, the USFDA conducted an inspection of the Medispray facility from 14 to 20 January 2025. The inspection concluded with the issuance of one observation in Form 483. In an email communication dated 11 April 2025, which was received by Cipla on 17 April 2025, the USFDA confirmed the VAI classification for the facility. The official announcement was made on Thursday, 17 April 2025, after market hours. Cipla is a global pharmaceutical company focused on agile and sustainable growth, complex generics, and deepening portfolios in our home markets of India, South Africa, North America, and key regulated and emerging markets. The pharma major's consolidated net profit jumped 48.73% to Rs 1,570.51 crore in Q3 FY25 as against Rs 1,055.90 crore reported in Q3 FY24. Total revenue from operations grew by 7.10% year on year (YoY) to Rs 7,072.97 crore in the quarter ended 31 December 2024. The counter rose 0.34% to Rs 1,520.65 on the BSE. Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Cipla allots 23,282 equity shares under ESOS
Cipla has allotted 23,282 fully paid-up equity shares of Rs 2 each, pursuant to exercise of employee stock options under the Employee Stock Option Scheme 2013-A of the Company. Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs 1,61,52,80,804 comprising of 80,76,40,402 equity shares of face value Rs 2 each.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Cipla to table results
Cipla will hold a meeting of the Board of Directors of the Company on 13 May 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
USFDA classifies cGMP inspection of Cipla's Virgonagar facility as VAI
Cipla has classified its current Good Manufacturing Practices (cGMP) inspection of the company's manufacturing facility in Virgonagar, Bengaluru, conducted between 7 - 13 November 2024, as Voluntary Action Indicated (VAI). Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Cipla to infuse ZAR 900 million in Cipla Medpro South Africa Proprietary Limited
Cipla will invest approx. ZAR 900 million in equity share capital of Cipla Medpro South Africa Proprietary Limited, a wholly-owned subsidiary of the Company in South Africa (CMSA). CMSA, is a wholly owned subsidiary of Cipla, and is the holding company for the group operations in South Africa. The group is involved in the manufacturing, marketing, and supply of pharmaceutical products. The investment will be utilised to reduce inter-group debt and improve the capital structure of CMSA and its subsidiaries. Powered by Capital Market - Live
4 months agoCapital Market - Live
Spotlight
Cipla Ltd up for third straight session
Cipla Ltd gained for a third straight session today. The stock is quoting at Rs 1456.1, up 2.26% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.42% on the day, quoting at 23261.2. The Sensex is at 76748.82, up 0.28%. Cipla Ltd has slipped around 4.77% in last one month. Meanwhile, Nifty Pharma index of which Cipla Ltd is a constituent, has slipped around 8.79% in last one month and is currently quoting at 21163.9, up 0.9% on the day. The volume in the stock stood at 10.82 lakh shares today, compared to the daily average of 14.63 lakh shares in last one month. The benchmark January futures contract for the stock is quoting at Rs 1462.15, up 2.87% on the day. Cipla Ltd is up 7.78% in last one year as compared to a 7.07% spurt in NIFTY and a 19.04% spurt in the Nifty Pharma index.The PE of the stock is 24.71 based on TTM earnings ending December 24.Powered by Capital Market - Live
4 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 9.51%, vs industry avg of 9.02%
Over the last 5 years, market share increased from 4.09% to 6.96%
Over the last 5 years, net income has grown at a yearly rate of 21.96%, vs industry avg of 15.29%